Skip to main content
Fig. 4 | Biomarker Research

Fig. 4

From: Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1–2 follicular lymphoma: a real-world multicenter study

Fig. 4

Comparison of clinical outcomes between patients with FL grade 1–2 and grade 3a in subsets with or without POD24. A-B Kaplan–Meier survival analysis of PFS A and OS B for FL1-2 and FL3a patients with POD24. 5-year PFS rate for FL1-2 patients with POD24 (58.8%, range 0.51–0.67), in comparison with FL3a patients with POD24 (36.4%, range 0.25–0.51); stratified P < 0.05. 5-year OS rate for FL1-2 patients with POD24 (82.2%, range 0.75–0.89), in comparison with FL3a patients with POD24 (66.0%, range 0.54–0.79); stratified P < 0.05. C-D Kaplan–Meier survival analysis of PFS C and OS D for FL1-2 and FL3a patients without POD24. 5-year PFS rate for FL1-2 patients without POD24 (69.9%, range 0.65–0.74), in comparison with FL3a patients without POD24 (57.8%, range 0.52–0.64); stratified P < 0.001. 5-year OS rate for FL1-2 patients without POD24 (96.2%, range 0.94–0.98), in comparison with FL3a patients without POD24 (96.8%, range 0.93–0.99); stratified P > 0.05

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us